Lazard Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02M | Sell |
6,702
-464
| -6% | -$71.1K | ﹤0.01% | 1154 |
|
|
2025
Q4 | $988K | Buy |
7,166
+2,439
| +52% | +$319K | ﹤0.01% | 1155 |
|
|
2025
Q3 | $606K | Hold |
4,727
| – | – | ﹤0.01% | 1293 |
|
|
2025
Q2 | $572K | Hold |
4,727
| – | – | ﹤0.01% | 1452 |
|
|
2025
Q1 | $526K | Sell |
4,727
-59
| -1% | -$6.28K | ﹤0.01% | 1396 |
|
|
2024
Q4 | $465K | Sell |
4,786
-506
| -10% | -$54K | ﹤0.01% | 1388 |
|
|
2024
Q3 | $608K | Sell |
5,292
-46
| -0.9% | -$5.22K | ﹤0.01% | 1304 |
|
|
2024
Q2 | $567K | Sell |
5,338
-606
| -10% | -$60.8K | ﹤0.01% | 1160 |
|
|
2024
Q1 | $574K | Sell |
5,944
-485
| -8% | -$49.7K | ﹤0.01% | 1029 |
|
|
2023
Q4 | $648K | Buy |
6,429
+5
| +0.1% | +$483 | ﹤0.01% | 1049 |
|
|
2023
Q3 | $653K | Sell |
6,424
-800
| -11% | -$81.2K | ﹤0.01% | 1078 |
|
|
2023
Q2 | $728K | Buy |
7,224
+735
| +11% | +$73.5K | ﹤0.01% | 1043 |
|
|
2023
Q1 | $596K | Sell |
6,489
-82
| -1% | -$7.16K | ﹤0.01% | 1079 |
|
|
2022
Q4 | $596K | Sell |
6,571
-1,367
| -17% | -$115K | ﹤0.01% | 1086 |
|
|
2022
Q3 | $602K | Sell |
7,938
-3,645
| -31% | -$302K | ﹤0.01% | 1069 |
|
|
2022
Q2 | $978K | Sell |
11,583
-1,108,040
| -99% | -$97.2M | ﹤0.01% | 1004 |
|
|
2022
Q1 | $98.2M | Sell |
1,119,623
-24,122
| -2% | -$2.09M | 0.11% | 163 |
|
|
2021
Q4 | $100M | Buy |
1,143,745
+18,605
| +2% | +$1.54M | 0.11% | 173 |
|
|
2021
Q3 | $92M | Sell |
1,125,140
-13,024
| -1% | -$1.17M | 0.1% | 187 |
|
|
2021
Q2 | $104M | Buy |
1,138,164
+2,223
| +0.2% | +$198K | 0.12% | 157 |
|
|
2021
Q1 | $97.1M | Sell |
1,135,941
-354,713
| -24% | -$31.8M | 0.12% | 152 |
|
|
2020
Q4 | $141M | Sell |
1,490,654
-374,806
| -20% | -$32.8M | 0.18% | 110 |
|
|
2020
Q3 | $162M | Sell |
1,865,460
-508,581
| -21% | -$44.1M | 0.23% | 90 |
|
|
2020
Q2 | $207M | Sell |
2,374,041
-317,469
| -12% | -$27.4M | 0.32% | 73 |
|
|
2020
Q1 | $222M | Buy |
2,691,510
+218,813
| +9% | +$19.5M | 0.41% | 57 |
|
|
2019
Q4 | $234M | Sell |
2,472,697
-19,215
| -0.8% | -$1.72M | 0.33% | 76 |
|
|
2019
Q3 | $217M | Sell |
2,491,912
-10,867
| -0.4% | -$976K | 0.36% | 71 |
|
|
2019
Q2 | $229M | Sell |
2,502,779
-316,122
| -11% | -$26.8M | 0.37% | 69 |
|
|
2019
Q1 | $243M | Buy |
2,818,901
+87,882
| +3% | +$7.05M | 0.4% | 66 |
|
|
2018
Q4 | $210M | Buy |
2,731,019
+646,279
| +31% | +$50.3M | 0.39% | 69 |
|
|
2018
Q3 | $161M | Buy |
2,084,740
+50,436
| +2% | +$3.73M | 0.26% | 93 |
|
|
2018
Q2 | $138M | Buy |
2,034,304
+31,215
| +2% | +$2.15M | 0.24% | 92 |
|
|
2018
Q1 | $145M | Buy |
2,003,089
+134,348
| +7% | +$10.2M | 0.25% | 88 |
|
|
2017
Q4 | $141M | Buy |
1,868,741
+103,046
| +6% | +$7.78M | 0.24% | 89 |
|
|
2017
Q3 | $136M | Buy |
1,765,695
+18,488
| +1% | +$1.4M | 0.25% | 86 |
|
|
2017
Q2 | $131M | Buy |
1,747,207
+18,538
| +1% | +$1.31M | 0.25% | 87 |
|
|
2017
Q1 | $115M | Sell |
1,728,669
-714,631
| -29% | -$47.6M | 0.22% | 83 |
|
|
2016
Q4 | $159M | Sell |
2,443,300
-189,968
| -7% | -$12.3M | 0.33% | 70 |
|
|
2016
Q3 | $186M | Buy |
2,633,268
+97,888
| +4% | +$7.13M | 0.37% | 70 |
|
|
2016
Q2 | $187M | Buy |
2,535,380
+37,201
| +1% | +$2.57M | 0.4% | 70 |
|
|
2016
Q1 | $162M | Sell |
2,498,179
-68,750
| -3% | -$4.68M | 0.35% | 75 |
|
|
2015
Q4 | $198M | Buy |
2,566,929
+10,342
| +0.4% | +$822K | 0.45% | 61 |
|
|
2015
Q3 | $211M | Buy |
2,556,587
+67,287
| +3% | +$5.99M | 0.5% | 57 |
|
|
2015
Q2 | $219M | Buy |
2,489,300
+116,590
| +5% | +$10.7M | 0.46% | 62 |
|
|
2015
Q1 | $210M | Buy |
2,372,710
+82,474
| +4% | +$7.32M | 0.45% | 62 |
|
|
2014
Q4 | $190M | Sell |
2,290,236
-1,239
| -0.1% | -$103K | 0.41% | 67 |
|
|
2014
Q3 | $193M | Sell |
2,291,475
-68,885
| -3% | -$5.57M | 0.42% | 70 |
|
|
2014
Q2 | $191M | Buy |
2,360,360
+92,375
| +4% | +$7.27M | 0.4% | 76 |
|
|
2014
Q1 | $173M | Buy |
2,267,985
+197,584
| +10% | +$14.4M | 0.39% | 80 |
|
|
2013
Q4 | $149M | Buy |
2,070,401
+60,190
| +3% | +$4.18M | 0.33% | 83 |
|
|
2013
Q3 | $138M | Buy |
2,010,211
+32,140
| +2% | +$2.13M | 0.33% | 81 |
|
|
2013
Q2 | $125M | Buy |
+1,978,071
| New | +$129M | 0.3% | 88 |
|
Other funds holding NVS
Lazard Asset Management's NVS Position: Q1 2026 in Review
Lazard Asset Management reduced its Novartis (NVS) stake by 6.5% in Q1 2026, selling an estimated $71.1K and leaving 6,702 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1154.
Lazard Asset Management first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $243M in Q1 2019. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Lazard Asset Management held 6,702 shares of Novartis worth $1.02M as of Q1 2026.
- Lazard Asset Management sold 464 Novartis shares in Q1 2026, an estimated $71.1K.
- Novartis made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1154 holding.
- Lazard Asset Management first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Lazard Asset Management's Novartis position peaked at $243M in Q1 2019.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.